Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Cognitive ImpairmentIntracerebral Hemorrhage
Interventions
DRUG

FCYC+Conventional treatment

Conventional treatment combined with oral administration of FCYC (four capsules, three times a day, orally) for a 12-week course of treatment.

DRUG

conventional treatment

The control group will receive the current gold standard treatment for ICH according to the guidelines (AHA/ASA 2022). This involves blood pressure and care.

Trial Locations (6)

100040

RECRUITING

Second Affiliated Hospital of Tsinghua University, Beijing

250102

RECRUITING

Shandong Public Health Clinical Center, Jinan

261041

RECRUITING

Weifang Hospital of Traditional Chinese Medicine, Weifang

475000

RECRUITING

Kaifeng Third People's Hospital, Kaifeng

650100

RECRUITING

Kunming Sanbo Brain Hospital, Kunming

066000

RECRUITING

Qinhuangdao Hospital of Traditional Chinese Medicine, Qinhuangdao

All Listed Sponsors
collaborator

Kaifeng Third People's Hospital

UNKNOWN

collaborator

Second Affiliated Hospital of Tsinghua University

OTHER

collaborator

Weifang Hospital of Traditional Chinese Medicine

UNKNOWN

collaborator

Shandong Public Health Clinical Center

OTHER_GOV

collaborator

Kunming Sanbo Brain Hospital

UNKNOWN

lead

Qinhuangdao Hospital of Traditional Chinese Medicine

OTHER